o2h kickstarter platinum partner

Become an o2h Discovery ‘Platinum Partner’ Platinum Partners are investors in biotech and are automatically eligible to provide new portfolio companies with an ‘o2h Kickstarter Award’ alongside their first investment into a small molecule therapeutic start-up

Apply now

o2h kickstarter awards: key highlights

5+

Editions completed
globally

20+

Awards provided
so far

15+

drug discovery programs
supported

about o2h discovery platinum partners

Building on the success of our o2h Kickstarter Awards, we’ve decided to invite investors in startups, whether they be Venture Capital, Venture Builders or Technology Transfer offices, to provide their new investments with a Kickstarter Award on ‘Auto Pilot’. This approach allows us to distribute more awards to companies helping them access this crucial support through their Pre Seed and Seed rounds.

We all know how tough it is to advance biotechs through the early stages, and our Platinum Partners will be working hard to support these companies with funds and more. This award aims to provide a chemistry boost to help recipient companies achieve their project milestones.

winners of o2h kickstarter competition

Alevin Therapeutics

Developing a platform of novel small molecule RGD integrin inhibitors with superior drug-like qualities

Kuano

De-risking and accelerating drug discovery by combining quantum and AI

Sevenless Therapeutics

Developing technique to uncover a novel chronic pain signaling target

Five Alarm Bio

Seeking to develop drugs to slow down the ageing process

Origami Therapeutics

Developing next-generation disease-modifying protein degraders and correctors

Psylo

Next-generation neuroscience for transformative treatments

Gertrude Biomedical

Creating innovative and transformational oncology therapeutics, accelerating progress towards a brighter future for sufferers of untreatable cancers.

Protai

AI-powered drug discovery startup that is revolutionizing the way new drugs can be discovered

Azadyne

Azadyne are a preclinical biotech company with a new approach to treating autoimmune disease. We have identified a new target within the body and a previously undrugged pathway.

ProteKt Therapeutics

ProteKt Therapeutics has discovered and developed a series of novel and selective molecules by applying unique computational methods and validating the inhibitors in clinically relevant assays

Monash University

Monash is a research-intensive university, known for some significant and lasting discoveries that have delivered impact beyond the academic community.

about the o2h kickstarter award

Launched in August 2022, the o2h Kickstarter competition aims to empower early-stage biotech companies striving to amplify their chemistry initiatives and secure their next funding milestone. We understand that drug discovery research is a complex phenomenon which often involves synthesising and screening vast numbers of molecules to uncover promising ‘hits.’ We’ve launched 5+ editions across diverse regions, including the UK, Australia, Israel, Italy, and the USA, garnering an overwhelming response with over 20 awards provided.

kickstarter benefits

team

Dedicated team of six FTE Synthetic chemists
of which two are experienced and four are trainees.

inventory

Access to a large inventory of chemicals and reagents for synthesis.

cost

Six synthetic chemists at approximately the cost of one chemist. No IP rights, equity, or obligation to continue with o2h discovery.

duration

The programme would be offered up to six months.

eligibility

The award is for pre-seed and seed stage small molecule focused biotech companies which have secured initial funding from o2h approved Investors.

winners feedback

More than 40 companies applied from across the globe, and here are the few companies who made it to the winners list.

Dr Neil Benson

CEO

Winning the o2h Kickstarter competition will significantly increase our chemistry resource and in turn accelerate delivery of our goals.

Read more onLinkedIn

Jason Rutt

CEO

We are absolutely delighted to win an inaugural kickstarter award. It's fantastic that one of Britains top CROs is prepared to back companies like ours.

Read more onLinkedIn

Chris Moody

Co-founder

the o2h kickstarter competition promises to be an excellent scheme allowing early-stage companies like ours to get access to synthetic chemistry.

Read more onLinkedIn

Vid Stojevic

CEO & Co-founder

The kickstarter provides vital access to chemists with the skills and knowledge to deliver on the promise of our technology.

Read more onLinkedIn

Dr Janette A Thomas

CEO

I am thrilled that Five Alarm Bio has been awarded the Kickstarter program. We will benefit from the extensive knowledge and enthusiasm of the o2h leadership and laboratory scientists.

Read more onLinkedIn